医学
神经组阅片室
放射科
甲状腺癌
试验装置
淋巴结
甲状腺癌
卷积神经网络
转移
阶段(地层学)
人工智能
癌症
甲状腺
内科学
计算机科学
神经学
古生物学
精神科
生物
作者
Liqiang Zhou,Shu‐E Zeng,Jianwei Xu,Wenzhi Lv,Dong Mei,Jia‐Jun Tu,Fan Jiang,Xin‐Wu Cui,Christoph F. Dietrich
标识
DOI:10.1186/s13244-023-01550-2
摘要
Abstract Objectives Precise determination of cervical lymph node metastasis (CLNM) involvement in patients with early-stage thyroid cancer is fairly significant for identifying appropriate cervical treatment options. However, it is almost impossible to directly judge lymph node metastasis based on the imaging information of early-stage thyroid cancer patients with clinically negative lymph nodes. Methods Preoperative US images (BMUS and CDFI) of 1031 clinically node negative PTC patients definitively diagnosed on pathology from two independent hospitals were divided into training set, validation set, internal test set, and external test set. An ensemble deep learning model based on ResNet-50 was built integrating clinical variables, BMUS, and CDFI images using a bagging classifier to predict metastasis of CLN. The final ensemble model performance was compared with expert interpretation. Results The ensemble deep convolutional neural network (DCNN) achieved high performance in predicting CLNM in the test sets examined, with area under the curve values of 0.86 (95% CI 0.78–0.94) for the internal test set and 0.77 (95% CI 0.68–0.87) for the external test set. Compared to all radiologists averaged, the ensemble DCNN model also exhibited improved performance in making predictions. For the external validation set, accuracy was 0.72 versus 0.59 ( p = 0.074), sensitivity was 0.75 versus 0.58 ( p = 0.039), and specificity was 0.69 versus 0.60 ( p = 0.078). Conclusions Deep learning can non-invasive predict CLNM for clinically node-negative PTC using conventional US imaging of thyroid cancer nodules and clinical variables in a multi-institutional dataset with superior accuracy, sensitivity, and specificity comparable to experts. Critical relevance statement Deep learning efficiently predicts CLNM for clinically node-negative PTC based on US images and clinical variables in an advantageous manner. Key points • A deep learning-based ensemble algorithm for predicting CLNM in PTC was developed. • Ultrasound AI analysis combined with clinical data has advantages in predicting CLNM. • Compared to all experts averaged, the DCNN model achieved higher test performance. Graphical Abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI